eniluracil has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Spector, T | 1 |
| Baccanari, DP; Davis, ST; Knick, VC; Spector, T | 1 |
| Adams, ER; Craig, DJ; Leffert, JJ; Pizzorno, G; Spector, T | 1 |
3 other study(ies) available for eniluracil and Experimental Neoplasms
| Article | Year |
|---|---|
A possible cause and remedy for the clinical failure of 5-fluorouracil plus eniluracil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; Neoplasms, Experimental; Rats; Rats, Inbred F344; Uracil | 2010 |
5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.
Topics: Administration, Oral; Animals; Biological Availability; Colonic Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Synergism; Female; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neoplasms, Experimental; Oxidoreductases; Plasmacytoma; Rats; Therapeutic Equivalency; Uracil | 1993 |
In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
Topics: Animals; Dihydrouracil Dehydrogenase (NADP); Enzyme Inhibitors; Fluorouracil; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oxidoreductases; Uracil | 1999 |